• No results found

Peripheral vascular diseases.pdf

N/A
N/A
Protected

Academic year: 2020

Share "Peripheral vascular diseases.pdf"

Copied!
40
0
0

Loading.... (view fulltext now)

Full text

(1)

PERIPHERAL VASCULAR

DISEASE

(2)

Pathophysiology

• Form of atherosclerosis • Progressive disease

– Usually has a slow onset and patients present with symptoms that gradually get worse OR…

(3)

• PVD is a generic term that encompasses vascular insufficiencies such as

arteriosclerosis, arterial stenosis, Raynaud’s phenomenon.

• Peripheral arteriosclerosis is common in the elderly and is often associated with

hypertension and hyperlipidemia.

(4)

Two types of PVD

• Functional

Doesn’t have an organic cause.

Doesn’t involve defects in blood vessels’ structure, usually short-term effects and come and go.

(5)

Types of PVD continued

• Organic

Caused by structural changes in the blood vessels, such as inflammation.

(6)

How Common is PVD?

• Affects about 1 in 20 people over the age of 50, or 8 million people in the US.

• Approximately 1 million people in SA are affected.

• PVD is only diagnosed in 50% of the population. • Symptomatic PVD carries at least a 30% risk of

death within 5 years and almost 50% within 10

(7)

Symptoms of PVD (

NB

)

• Leg or hip pain during walking (intermittent claudication).

• The pain stops when you rest.

• Numbness, tingling or weakness in the legs. • Burning or aching pain in feet or toes when

resting.

• Sore on leg or foot that won’t heal. • Cold legs or feet.

(8)

Clarification of Terminology

• Claudication – when at rest / during low

energy tasks the patient experiences no

pain, as the blood flow is sufficient,

HOWEVER, as soon as the patient walks

fast / runs / does any activities that causes

fatigue, the blood flow to the limb is not

(9)

The 5 P’s (

NB

)

• Peripheral signs of PVD are the classic 5 P’s

Pulselessness

Paralysis

Paraesthesia

Pain

(10)

• Paralysis and paraesthesia suggest limb-threatening ischemia and mandate prompt evaluation and consultation.

• Advanced PVD may manifest as mottling in a “fishnet pattern”, pulselessness, numbness, or cyanosis. Paralysis may follow, and the

extremity may become cold; gangrene

eventaully may be seen. Poorly healing injuries or ulcers in the extremities help provide

(11)

Who is at risk for PVD?

• Over the age of 50 • Smokers

• Diabetics

• Overweight (especially with syndrome X or hyperinsulinism)

• Male gender

• Sedentary people

(12)

Pain Scale

• A subjective grading scale for PVD pain is as follows:

Grade 1: Definite discomfort or pain, but only of initial or modest levels (established, but minimal).

Grade 2: Moderate discomfort or pain from which the patient’s attention can be diverted, for example by

conversation.

Grade 3: Intense pain (short of Grade 4) from which the patient’s attention cannot be diverted.

(13)

How is PVD Diagnosed?

• Ankle-Brachial Index Test (ABI)

The blood pressure in your arms and ankles is checked using a regular blood pressure cuff and a special ultrasound stethoscope called a Doppler.

The pressure in your ankle is compared to the pressure in your arm to determine how well

your blood is flowing.

(14)

ABI

• Measurements are usually taken at rest and

after standardized treadmill exercise (i.e.. For 5 min. at 2mph, 12%).

• A normal resting ABI is 1 or 1.1.

• An index of 0.9 or less indicates the presence of obstructive disease.

• 0.5 or less suggests multiple-level arterial disease.

(15)

Duplex Ultrasonography and

Doppler Color-Flow Imaging

• Technical advances in ultrasonography have allowed reproducible measurements of blood vessels and blood flow as well as

standardization of criteria for assessment of PVD.

• Doppler color-flow imaging are useful in

(16)

Magnetic Resonance Imaging

and Angiography

• Useful in evaluating arterial dissection and characterizing vessel-wall morphology

(including hematoma or thrombus).

(17)

Treatment for PVD (

NB

)

• Severe lower extremity PVD is treated initially with cardiovascular disease risk factor modification:

Exercise training

Medication

Diet

Stop Smoking

Interventional Radiology

Surgery

(18)

Exercise

• Research has shown that regular exercise is the most consistently effective treatment for PVD. • Patients who have taken part in a regular

exercise program for at least 3 months have

seen substantial increases in the distances they are able to walk without experiencing painful

(19)

Exercise Prescription

• Training Intensity

Initial

• Set by result of peak treadmill.

• Starting exercise work load brings on claudication pain.

Subsequent

• Speed or grade increased if patient walks > 10 minutes.

(20)

Exercise Prescription

• Duration

Initial

• 35 minutes (intermittent walking)

Subsequent

• Add 5 minutes every session until 50

(21)

Exercise Prescription

• Frequency

3-5 times per week.

• Specificity of Activity

(22)

Stop Smoking

• On average, smokers are diagnosed with PVD as much as 10 years earlier than non-smokers. • Stopping smoking now is the single most

important thing you can do to halt the

(23)

Medications

• Drugs that lower cholesterol or control high blood pressure.

• Decrease blood viscosity.

Trental, Persantine, or Coumadin

• Antiplatlet agents: their primary long-term benefit is reduction in cardiovascular events and mortality.

ASA doses of 75 to 325mg QD have shown protective benefits.

Ticlid and Plavix also have shown promise in

(24)

Interventional Radiology

Treatments

• Angioplasty • Stents

(25)

Gene-Based Therapy

• The field of molecular genetics has provided new understanding of vascular physiology and pathology and has opened exciting frontiers in the treatment of PVD.

• Direct gene transfer by intramuscular injection of DNA encoded with vascular growth factors has resulted in growth of new vessels and

(26)

Surgical Treatments for PVD

(27)
(28)

Aneurysms

• Most common lethal peripheral vascular abnormality.

An artery whose diameter is 1.5 times the normal. • Aortic aneurysms are caused by weakening of the

artery walls due to atherosclerosis. The weakened walls balloon out, forming an aneurysm.

(29)

Aortoiliac Occlusive Disease

• Typically involves the distal abdominal aorta as well as the common and external iliac

arteries.

• Aortobifemoral bypass with a prosthetic graft has been the traditional treatment of choice for aortoiliac occlusive disease since the

1960’s.

• The operative morbidity and mortality are in the 2% range, and long-term patency

(30)

Superficial Femoral Occlusive

Disease

• Presents with symptoms of claudication of the calf and sole of the foot.

Usually improves as collateral circulation develops.

(31)

Tibial Artery Disease

• Distal atherosclerotic disease involving the

tibioperoneal trunk and the tibial vessels is the most difficult to treat and leads to the greatest morbidity and tissue loss.

(32)

Upper Extremity Disease

• Atherosclerotic disease involving the arms is almost always limited to the larger proximal vessels and rarely involves the brachial,

radial, or ulnar arteries.

• Although these patients have no symptoms, they can have a large discrepancy in BP

between the left and right arms.

(33)

Thrombosis

• A thrombus, or blood clot, within a blood vessel.

• Normally, a blood clot forms to prevent

bleeding but a thrombus is an abnormal blood clot in the vessel when it is not even

punctured.

• The clotting process may be encouraged by the buildup of fatty acids on the vessel walls. • Thrombosis in the vein may cause pain and

(34)

Deep Venous Thrombosis

• A blood clot in a deep vein.

• May form on the valves within the vein, and may subsequently increase in size to totally occlude the vein.

• Sometimes parts of the clot may break off

and travel in the bloodstream to the lungs and cause serious health problems (pulmonary

embolism).

• DVT is perhaps the most dangerous problem. • Patients with DVT have a 30 to 40% risk of

(35)

Phlebitis

• Inflammation of the leg veins. • Two types:

Inflammation of the veins on the surface of the leg (more common).

Inflammation of the deep veins of the leg. • Phlebitis is caused by an infection or injury. • Can cause a blood clot to form and this clot

(36)

Pulmonary Embolism

• An embolus is a clot or any other piece of material that is carried around in the blood. • Pulmonary embolism is where the embolus

gets stuck in a vessel going to the lungs.

• The only way a clot can go to a vessel in the lungs is if it passes through the heart and is pumped out of the pulmonary artery.

(37)

Varicose Veins

• Caused because either the blood flow is too slow making the vein pile up with blood or the valve in the vein is not working well so the blood falls

down due to gravity and piles up in the veins of the legs.

• Sclerotherapy: Irritant chemical is injected into

the veins, causing them to scar and seal off. This “detours” the blood to nearby healthier veins.

• Stripping: Procedure used to remove larger

(38)

• Surgery continues to play an important role in the management of peripheral vascular

disease.

• Revascularization procedures provide

excellent outcomes for many patients at risk for loss of a limb or seriously impaired quality of life.

• Although endovascular techniques are now being used for managing many vascular

(39)
(40)

References

Related documents

unanticipated increases in medical costs (including increased intensity or medical utilization as a result of flu or otherwise; changes in membership mix to higher cost

Therefore, as part of the Triple-S project, CWSA and IRC have been (further) developing a system for comprehensive monitoring of rural water services, building

This chapter discusses content-based recommendation systems, i.e., systems that recommend an item to a user based upon a description of the item and a profile of the

The Contemporary RN Case Manager™ Certificate Program is designed specifically to address the educational needs of registered nurses who are expanding their practices to include

expressly provided in the Contract Documents. Bids shall not include federal excise tax or state sales tax for materials to be incorporated in, or totally consumed in the

Keywords : Asymmetric Pricing, Channel Pricing, Costs of Price Adjustment, Menu Costs, Wholesale Prices, Channels of Distribution, Retailing, Economic Model, Scanner Data..

The graphs suggested that negative schizotypy moderated the association between trial type and SWM performance such that high and low negative schizotypy was unrelated to within

ties. Communities, like Pittsburgh, using their land use power, are mitigat- ing climate change by defining the types of emerging sources of renewable power and permitting